Category

Essential Injectable
PARAMUS, UNITED STATES, August 4, 2021 /EINPresswire.com/ — WG Critical Care, LLC will be introducing the first and only FDA-approved, Ready-To-Use (RTU) Midazolam in 0.9% Sodium Chloride Injection CIV in single-dose bags. Midazolam is currently controlled in schedule IV of the Controlled Substance Act. The launch of Ready-To-Use Midazolam in 0.9% Sodium Chloride Injection CIV...
Read More
PARAMUS, N.J., Jan. 15, 2019 /PRNewswire/ — WG Critical Care (WGCC), A Pharmasphere company, has launched the first and only FDA approved Calcium Gluconate in Sodium Chloride Injection in a Ready-To-Use Bag. “In addition to addressing a chronic drug shortage of this product, I’m excited to add another unique product to our expanding portfolio,” says...
Read More
PARAMUS, N.J., March 1, 2018 /PRNewswire/ — WG Critical Care launched the first and only generic ready-to-use Esmolol HCl in Water for Injection (WFI), 2500 mg/250 mL (10 mg/mL) and Double Strength 2000 mg/100 mL (20 mg/mL). Esmolol is a cardiovascular agent indicated for rapid control of ventricular rate in patients with atrial fibrillation or...
Read More
PARAMUS, N.J., Oct. 11, 2016 /PRNewswire/ —  (WGCC), a wholly owned subsidiary of PharmaSphere, Inc., announced today that it has launched the first and only 400 mcg/4 mL and 1000 mcg/10 mL multi-dose vials. Dexmedetomidine HCl Injection is currently sold as a 2 mL vial by multiple manufacturers. Dexmedetomidine is also available in ready to...
Read More
© 2021 WG Critical Care, LLC | A PharmaSphere Company | 120 Rte 17 N, Paramus, NJ 07652